Stay updated with breaking news from Compassionate Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This article was originally published by the National Organization for the Reform of Marijuana Laws (NORML) and appears here with permission. Lawmakers have advanced two bills to the desk of Democratic Gov. Gavin Newsom that seek to expand the rights of cannabis consumers.
ABIONYX Pharma announced that the company has been granted a new Compassionate Access Authorization in Europe for CER-001 in the rare, untreated kidney disease LCAT Deficiency. This is the fourth...
10.07.2023 - Regulatory News: ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies based on the world's only natural recombinant ApoA-I, announces that the ...
Coverage for a potentially lifesaving drug has been denied to a Vancouver man with a stage four cancer, even though the drug is approved by Health Canada, and was prescribed by his oncologist.
Entrectinib, a targeted drug that had shown positive results in tumours that had the same gene expression, costs $10,200 a month.